Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
I couldn’t believe my eyes as the Pro Medicus Limited (ASX:PME) share price charged over $29 a pop today.
Clinuvel Pharmaceuticals Limited (ASX:CUV) shares are up nearly 90% year-to-date and 200% over the last 12 months. Is it too late to buy?
Is it just me or do Australia’s best investors have something in common?
Adding investments in high growth ASX small cap shares like Serko Ltd (ASX:SKO) and Volpara (ASX:VHT) might be spice up your Australian shares portfolio.
The Pro Medicus Limited (ASX:PME) share price keeps going up and up, will it ever stop?
Shares in med-tech market darling Pro Medicus (ASX: PME) have carved out fresh record highs recently, following a more than doubling in the share price over the past 12 months.
The Pro Medicus Limited (ASX:PME) share price is up around 3.5% thanks to a broker.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.18% at lunch.
The Pro Medicus Limited (ASX:PME) share price is up almost 5% and has hit an all-time high today on the back of pleasing news.
